Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Prognostic Factors for Survival of Elderly Patients with Acute Myeloid Leukemia after Intensive Chemotherapy: Validation of 3 Popular Prognostic Models

Ebru Koca, MD, Aysun Halacoglu, MD, Umit Yavuz Malkan, MD, Deniz Arica, MD, Sema Karakus, MD, Hakan Goker, MD, Ibrahim C. Haznedaroglu, MD, Nilgun Sayinalp, MD, Yahya Buyukasik, MD

Blood (2014) 124 (21): 5332.

https://doi.org/10.1182/blood.V124.21.5332.5332

Published: 2014

Journal Articles

Impact of Pretransplant Cytogenetics and Marrow Remission Status on Outcome of Patients with Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Allogeneic Stem Cell Transplantation Conditioned with Busulfan and Fludarabine

Ebru Koca, Rima M Saliba, Marcos De Lima, Uday Popat, Partow Kebriaei, Gabriela Rondon, Sergio Giralt, Borje S Andersson, Richard E Champlin

Blood (2008) 112 (11): 341.

https://doi.org/10.1182/blood.V112.11.341.341

Published: 2008

Journal Articles

Allogeneic Transplantation (HCT) for Myelodysplastic Syndrome:Recent MDACC Experience.

Uday Popat, MD, Marcos J de Lima, MD, Touch Ativitavas, MD, Gabriela Rondon, MD, Leandro de Padua Silva, MD, Ebru Koca, MD, Weiqing Zhang, MD, Amin Alousi, MD, Paolo Anderlini, MD, Sergio A. Giralt, MD, Chitra M. Hosing, MD, Roy Jones, MD, PhD, Partow Kebriaei, MD, Issa Khouri, MD, Yago Nieto, MD, PhD, Muzaffar H. Qazilbash, MD, Borje S. Andersson, MD, PhD, Richard Champlin, MD

Blood (2008) 112 (11): 1131.

https://doi.org/10.1182/blood.V112.11.1131.1131

Published: 2008

Journal Articles

Role of Brain-Type Natriuretic Peptide and Cardiac Troponins as Predictors of Outcome in Multiple Myeloma

Ebru Koca, Gaurav Parikh, Ali Imran Amjad, Floralyn L Mendoza, Chitra M Hosing, Uday Popat, Richard E Champlin, Sergio Giralt, Muzaffar H. Qazilbash

Blood (2008) 112 (11): 4457.

https://doi.org/10.1182/blood.V112.11.4457.4457

Published: 2008

Journal Articles

Donor Type Impacts the Incidence of Severe Acute but Not Chronic Graft- Versus-Host Disease (GVHD) after Reduced Toxicity Conditioning and Allogeneic Stem Cell Transplantation (ASCT) for Treatment of AML/MDS.

Ri ma M. Saliba, Krishna V. Komanduri, Ebru Koca, Amin M. Alousi, Sergio Giralt, Borje S. Andersson, Weiqing Zhang, Gabriela Rondon, Uday R. Popat, Partow Kebriaei, Marcos de Lima, Richard E. Champlin

Blood (2008) 112 (11): 2227.

https://doi.org/10.1182/blood.V112.11.2227.2227

Published: 2008

Journal Articles

Over-Expression of the Local Bone Marrow Renin-Angiotensin System in Acute Myeloid Leukemia.

Yavuz Beyazit, MD, Salih Aksu, MD, Ibrahim Celalettin Haznedaroglu, MD, Murat Kekilli, MD, Muge Misirlioglu, MD, Serdar Tuncer, MD, Ebru Koca, MD, Deniz Cetiner, MD, Yahya Buyukasik, MD, Nilgun Sayinalp, MD, Hakan Goker, MD, Osman Ilhami Ozcebe, MD

Blood (2005) 106 (11): 4567.

https://doi.org/10.1182/blood.V106.11.4567.4567

Published: 2005

NARROW

Prognostic Factors for Survival of Elderly Patients with Acute Myeloid Leukemia after Intensive Chemotherapy: Validation of 3 Popular Prognostic Models

Impact of Pretransplant Cytogenetics and Marrow Remission Status on Outcome of Patients with Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Allogeneic Stem Cell Transplantation Conditioned with Busulfan and Fludarabine

Allogeneic Transplantation (HCT) for Myelodysplastic Syndrome:Recent MDACC Experience.

Role of Brain-Type Natriuretic Peptide and Cardiac Troponins as Predictors of Outcome in Multiple Myeloma

Donor Type Impacts the Incidence of Severe Acute but Not Chronic Graft- Versus-Host Disease (GVHD) after Reduced Toxicity Conditioning and Allogeneic Stem Cell Transplantation (ASCT) for Treatment of AML/MDS.

Over-Expression of the Local Bone Marrow Renin-Angiotensin System in Acute Myeloid Leukemia.

Email alerts

ASH Publications

American Society of Hematology

Prognostic Factors for Survival of Elderly Patients with Acute Myeloid Leukemia after Intensive Chemotherapy: Validation of 3 Popular Prognostic Models

Impact of Pretransplant Cytogenetics and Marrow Remission Status on Outcome of Patients with Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Allogeneic Stem Cell Transplantation Conditioned with Busulfan and Fludarabine

Allogeneic Transplantation (HCT) for Myelodysplastic Syndrome:Recent MDACC Experience.

Role of Brain-Type Natriuretic Peptide and Cardiac Troponins as Predictors of Outcome in Multiple Myeloma

Donor Type Impacts the Incidence of Severe Acute but Not Chronic Graft- Versus-Host Disease (GVHD) after Reduced Toxicity Conditioning and Allogeneic Stem Cell Transplantation (ASCT) for Treatment of AML/MDS.

Over-Expression of the Local Bone Marrow Renin-Angiotensin System in Acute Myeloid Leukemia.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only